German Medical Association Calls for Ban on Disposable E-cigarettes

Regulations by 2FIRSTS.ai

Nov.20.2023

German Medical Association Calls for Ban on Disposable E-cigarettes

German doctors in North Rhine-Westphalia call for a ban on disposable e-cigarettes due to health concerns and environmental pollution.

According to a report from Zeit, the medical association of North Rhine-Westphalia in Germany has advocated for a ban on disposable e-cigarettes at a meeting held in Dusseldorf on November 18th.

The association points out that when e-liquid is heated, it produces aerosols that may harm the heart and respiratory system, as well as potentially trigger respiratory diseases and allergies. In addition, disposable e-cigarettes are typically discarded in regular trash bins rather than electronic waste recycling stations. Consequently, the plastic, metal, and lithium-ion batteries that come with them cause significant environmental pollution.

The association is calling for an immediate prohibition or at least restrictions on the production and sale of disposable e-cigarettes. According to the association's report, sales of e-cigarettes and disposable e-cigarettes have increased by 40% between 2021 and 2022.

Association President Rudolf Heng stated that the various shapes and vibrant colors of e-cigarettes primarily attract adolescent consumers. He called on legislators to better protect children, teenagers, and pregnant women from the harms of secondhand smoke.

References:

[1] Gesundheit: Ärzte fordern Verbot von Einweg-E-Zigaretten

Also Read:

[1] China's E-cigarette Exports to Germany in September 2023

[2] Growing Use of E-Cigarettes Among German Teenagers Sparks Concern

[3] Germany Abandons Smoking Ban in Cars with Children and Pregnant Women

#E-cigarette #E-cigarettes and Tobacco #European Union

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most

In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.

Oct.21

Expert Warns in 2Firsts Op-ed: Proposed COP11 Ban on Nicotine Pouches Would Be a Global Public Health Mistake

As global delegates prepare for COP11, a leaked EU position paper has sparked fresh debate over the future of nicotine pouch regulation. In an exclusive op-ed submitted to 2Firsts, Dr. Nveed Chaudhary, Chair of GINN’s Scientific Committee, argues that banning nicotine pouches would be a profound public health mistake—one that ignores harm reduction science and risks reversing global progress in smoking cessation.

Nov.03

WHO Chief Warns of E-Cigarette Threat to Youth as COP11 Opens in Geneva

More than 1,400 delegates from 162 Parties convened in Geneva on November 17 for the Eleventh Session of the Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (WHO FCTC). WHO Director-General Tedros Adhanom Ghebreyesus opened the session with a stark warning: tobacco and nicotine companies are targeting schools as the “new front line” to recruit a generation of addicts through e-cigarettes and nicotine pouches.

Nov.18 by 2FIRSTS.ai

British Museum Ends Long-Running Sponsorship with Japan Tobacco International

According to The Guardian, the British Museum has ended its 15-year sponsorship with Japan Tobacco International after government inquiries into whether the deal breached WHO tobacco-control rules. Critics had long opposed the partnership, while the museum said sponsorship remains essential for its financial stability and public access.